Da An Gene Co Ltd of Sun Yat-Sen University Market Cap ($1.10 Billion)
Market Cap & Net Worth: Da An Gene Co Ltd of Sun Yat-Sen University (002030)
Da An Gene Co Ltd of Sun Yat-Sen University market cap. Da An Gene Co Ltd of Sun Yat-Sen University (SHE:002030) has a market capitalization of $1.10 Billion (CN¥7.49 Billion) as of November 6, 2026. Listed on the SHE stock exchange, this China-based company holds position #8245 globally and #1852 in its home market, demonstrating a 2.10% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Da An Gene Co Ltd of Sun Yat-Sen University's stock price CN¥5.34 by its total outstanding shares 1403446032 (1.40 Billion). Also see 002030 cash generation efficiency for how efficiently the company converts equity into cash flow.
Da An Gene Co Ltd of Sun Yat-Sen University Market Cap History (2015–2026)
Da An Gene Co Ltd of Sun Yat-Sen University market cap history from 2015 to 2026. Data shows change from $3.14 Billion to $1.10 Billion (-9.33% CAGR). Check 002030 stock price for real-time trading data and today's change.
Da An Gene Co Ltd of Sun Yat-Sen University Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Da An Gene Co Ltd of Sun Yat-Sen University's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 002030 net assets growth trend to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
1.62x
Da An Gene Co Ltd of Sun Yat-Sen University's market cap is 1.62 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.95 Billion | $1.61 Billion | $106.69 Million | 1.21x | 18.24x |
| 2017 | $1.56 Billion | $1.54 Billion | $86.45 Million | 1.01x | 18.06x |
| 2018 | $940.67 Million | $1.48 Billion | $101.58 Million | 0.64x | 9.26x |
| 2019 | $1.07 Billion | $1.10 Billion | $92.18 Million | 0.97x | 11.60x |
| 2020 | $3.51 Billion | $5.34 Billion | $2.45 Billion | 0.66x | 1.43x |
| 2021 | $3.34 Billion | $7.66 Billion | $3.62 Billion | 0.44x | 0.92x |
| 2022 | $2.74 Billion | $12.05 Billion | $5.41 Billion | 0.23x | 0.51x |
| 2023 | $1.98 Billion | $1.18 Billion | $104.66 Million | 1.68x | 18.95x |
| 2024 | $1.17 Billion | $853.02 Million | -$925.17 Million | 1.37x | N/A |
| 2025 | $1.22 Billion | $757.66 Million | -$744.38 Million | 1.62x | N/A |
Competitor Companies of 002030 by Market Capitalization
Companies near Da An Gene Co Ltd of Sun Yat-Sen University in the global market cap rankings as of November 6, 2026. Also see Da An Gene Co Ltd of Sun Yat-Sen Univers asset portfolio for a full breakdown of the balance sheet.
Key companies related to Da An Gene Co Ltd of Sun Yat-Sen University by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #181 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #373 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #415 globally with a market cap of $67.74 Billion USD ( AU$95.74 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #503 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #181 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $549.04 |
| #373 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $930.67 |
| #415 | CSL Ltd | AU:CSL | $67.74 Billion | AU$197.34 |
| #503 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $258.38 |
Market Capitalization of Da An Gene Co Ltd of Sun Yat-Sen University (2015–2026)
Market capitalization of Da An Gene Co Ltd of Sun Yat-Sen University from 2015 to today. Between 2015 and today, Da An Gene Co Ltd of Sun Yat-Sen University's market cap moved from $3.14 Billion to $ 1.10 Billion, with a yearly change of -9.33%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.10 Billion | -10.40% |
| 2025 | CN¥1.22 Billion | +4.93% |
| 2024 | CN¥1.17 Billion | -41.17% |
| 2023 | CN¥1.98 Billion | -27.75% |
| 2022 | CN¥2.74 Billion | -17.74% |
| 2021 | CN¥3.34 Billion | -4.95% |
| 2020 | CN¥3.51 Billion | +228.37% |
| 2019 | CN¥1.07 Billion | +13.64% |
| 2018 | CN¥940.67 Million | -39.76% |
| 2017 | CN¥1.56 Billion | -19.73% |
| 2016 | CN¥1.95 Billion | -37.97% |
| 2015 | CN¥3.14 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 5th, 2026 the market cap of Da An Gene Co Ltd of Sun Yat-Sen University was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.10 Billion USD |
| MoneyControl | $1.10 Billion USD |
| MarketWatch | $1.10 Billion USD |
| marketcap.company | $1.10 Billion USD |
| Reuters | $1.10 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Da An Gene Co Ltd of Sun Yat-Sen University
Daan Gene Co., Ltd., together with its subsidiaries, researches and develops, manufactures, and sells clinical test reagents, instruments, and supporting consumables in China. It operates through two segments, Biological Products and Related Business and Financial Business. The company offers PCR testing kits, including hepatitis virus, human papillomavirus (HPV), sexually transmitted infections … Read more